Stock comparison
Avantor, Inc. is 4.8x more valuable than Alamar Biosciences, Inc. by market capitalization ($10.22 B vs $2.13 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AVTR is larger
Avantor, Inc. is 4.8x more valuable than Alamar Biosciences, Inc. by market capitalization ($10.22 B vs $2.13 B).
Market value leader
AVTR
Avantor, Inc. is 4.8x more valuable than Alamar Biosciences, Inc. by market capitalization ($10.22 B vs $2.13 B).
| Metric | ALMR | AVTR |
|---|---|---|
| Market cap | $2.13 B | $10.22 B |
| US-listed rank | #2098 | #943 |
| Revenue (latest FY) | - | $6.55B |
| Net income (latest FY) | - | -$530.20M |
| Net margin | - | -8.1% |
| P/E (trailing FY) | - | - |
| SEC filings | 38 | 763 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Avantor, Inc. is 4.8x more valuable than Alamar Biosciences, Inc. by market capitalization ($10.22 B vs $2.13 B).
Full pages: Alamar Biosciences, Inc. and Avantor, Inc., or browse the full rankings.